Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | F9 | P00740 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | TOP1 | P11387 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8907605 | 0.83 | ABCG2 (0.52) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14629716 | 0.82 | F9 (0.43) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14599692 | 0.77 | FFAR1 (0.38) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14629730 | 0.76 | MAPT (0.40) | KDM4EHSD17B10ALDH1A1TP53MAPT | |
| SCHEMBL14599678 | 0.76 | ATP4A (0.38) | KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL14599687 | 0.74 | TOP1 (0.39) | ABCG2TOP1CYCS | |
| SCHEMBL14599689 | 0.74 | ADORA2B (0.39) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14599694 | 0.73 | F9 (0.37) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14599693 | 0.73 | F9 (0.36) | PDE3BPDE3AP2RY12KDM4EHSD17B10 | |
| SCHEMBL14599680 | 0.72 | STAT3 (0.44) | TOP1CYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | SCO2, CBR3, CBR1 | PDE3B 4433/4885PDE3A 4169/4885P2RY12 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.